Real-World Claims Analysis to Characterize the Burden of Tardive Dyskinesia in Long-Term Care Settings
Our findings demonstrated individuals with TD in LTC settings have a high comorbidity burden and polypharmacy, particularly for medications with anticholinergic properties. Further investigation is warranted to evaluate the impact of TD in older adults in LTC settings and explore interventional practices that can improve clinical outcomes, such as falls with injury and activities of daily living decline.
Authors
- Gideon Aweh
- Morgan Bron (ORCID: https://orcid.org/0000-0002-2496-3501)
- Eric Jen (ORCID: https://orcid.org/0000-0001-7322-2403)
- Amita Patel
Institutions
- Dayton Clinical Oncology Program (US)
- STATinMED (United States) (US)
- Memorial Hospital (US)
- Neurocrine Biosciences (United States) (US)
Publication Details
- Journal
- Neurology and Therapy
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1007/s40120-025-00820-z
- Primary Topic
- Dysphagia Assessment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Neurocrine Biosciences